Pfizer Holds Out Hope For C. Diff Vaccine Despite Clinical, Commercial Failures

Sanofi’s Candidate Failed, Merck’s Zinplava Never Gained Traction

Clostridium difficile bacteria, computer illustration
C. diff is most common in older adults • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D